AntibodyLimited DatastaleTesaro, Inc.Phase 3
TSR-042 (Dostarlimab, Dostarlimab (TSR-042))
Ovarian Neoplasms; Ovarian, Fallopian Tube and Primary Peritoneal Carcinoma · Ovarian Neoplasms
#OvarianNeoplasms#Antibody#Phase3#monoclonal-antibody#Ovarian+2
Trials 1Status Recruiting